Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-17

Clinical Trial Update: Discontinuation of Antiviral Therapy as a Strategy to Cure Hepatitis B [NA]

View source ↗

Summary

The update discusses a study exploring whether discontinuing antiviral therapy can lead to cure in chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Göteborg University | Conditions: Hepatitis B, Chronic | NA | Status: ACTIVE_NOT_RECRUITING